Raymond James & Associates Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Raymond James & Associates increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 702,772 shares of the medical device company's stock after purchasing an additional 55,666 shares during the quarter. Raymond James & Associates owned 0.35% of Cooper Companies worth $77,544,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company's stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares during the period. Capital World Investors raised its position in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company's stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the period. Janus Henderson Group PLC raised its position in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company's stock worth $348,723,000 after acquiring an additional 2,532,186 shares during the period. Bessemer Group Inc. boosted its stake in shares of Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company's stock worth $203,013,000 after acquiring an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB acquired a new stake in shares of Cooper Companies during the 1st quarter valued at about $139,246,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analysts Set New Price Targets

COO has been the topic of several research analyst reports. Jefferies Financial Group raised Cooper Companies from a "hold" rating to a "buy" rating and raised their price objective for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Piper Sandler raised their target price on Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Stifel Nicolaus reiterated a "buy" rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Finally, Morgan Stanley upped their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $115.00.

Insider Activity

In related news, COO Daniel G. Mcbride sold 114,992 shares of the company's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, COO Daniel G. Mcbride sold 114,992 shares of the company's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Brian G. Andrews sold 24,788 shares of the business's stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares of the company's stock, valued at approximately $700,422.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 in the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded down $1.54 during trading hours on Monday, reaching $106.72. The stock had a trading volume of 764,905 shares, compared to its average volume of 1,104,046. The firm has a 50-day moving average of $104.28 and a 200-day moving average of $96.42. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $112.38. The firm has a market cap of $21.25 billion, a price-to-earnings ratio of 62.78, a PEG ratio of 2.56 and a beta of 0.98. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company's revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the company earned $0.84 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.